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Changes in bone macro- and 
microstructure in diabetic obese 
mice revealed by high resolution 
microfocus X-ray computed 
tomography
G. Kerckhofs1,2,*, M. Durand1,2,3,4,*, R. Vangoitsenhoven5, C. Marin1,2, B. Van der Schueren5, 
G. Carmeliet5, F. P. Luyten1,2, L. Geris2,6,7 & K. Vandamme2,8
High resolution microfocus X-ray computed tomography (HR-microCT) was employed to characterize 
the structural alterations of the cortical and trabecular bone in a mouse model of obesity-driven type 
2 diabetes (T2DM). C57Bl/6J mice were randomly assigned for 14 weeks to either a control diet-fed 
(CTRL) or a high fat diet (HFD)-fed group developing obesity, hyperglycaemia and insulin resistance. 
The HFD group showed an increased trabecular thickness and a decreased trabecular number compared 
to CTRL animals. Midshaft tibia intracortical porosity was assessed at two spatial image resolutions. 
At 2 μm scale, no change was observed in the intracortical structure. At 1 μm scale, a decrease in the 
cortical vascular porosity of the HFD bone was evidenced. The study of a group of 8 week old animals 
corresponding to animals at the start of the diet challenge revealed that the decreased vascular porosity 
was T2DM-dependant and not related to the ageing process. Our results offer an unprecedented ultra-
characterization of the T2DM compromised skeletal micro-architecture and highlight an unrevealed 
T2DM-related decrease in the cortical vascular porosity, potentially affecting the bone health and 
fragility. Additionally, it provides some insights into the technical challenge facing the assessment of 
the rodent bone structure using HR-microCT imaging.
Diabetes Mellitus (DM) affects 56.3 million individuals in Europe and about 387 million worldwide (http://www.
idf.org/). The current pandemic of the most common type of diabetes, type 2 diabetes (T2DM), largely results 
from a lifestyle with low physical activity and a high caloric diet leading to obesity. Obesity-induced T2DM is 
characterized by a progressive development of insulin resistance in liver and peripheral tissues accompanied by 
a defective insulin secretion from pancreatic beta cells leading to overt hyperglycaemia. Chronic hyperglycaemia 
results in microvascular complications (diabetic nephropathy, neuropathy, and retinopathy) as well as macrovas-
cular morbidity (coronary artery disease, peripheral arterial disease, and stroke) and ultimately increased mortal-
ity1. Substantial progress in diabetes monitoring and treatment has significantly increased the life expectancy of 
patients. As patients live longer, other comorbidities related to the diabetic condition have emerged, including a 
compromised skeletal health2. Indeed, obese patients with T2DM experienced a 40 to 70% increased fracture risk 
despite a paradoxal normal to relatively high bone mineral density (BMD) compared to control subjects3–6. These 
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fractures are particularly problematic because T2DM patients also exhibit longer and impaired fracture healing 
and poorer outcomes after fracture7. The mechanisms underlying the poor skeletal health in T2DM patients 
is currently not well understood, but is likely to be multifactorial and to include deficits in both bone material 
properties and bone macro- and microstructure. Indeed, one of the potential accounting mechanism is the dete-
rioration of the bone matrix due to the accumulation of advanced glycation end products (AGEs)8. Recently, 
Poundarik et al. showed a marked reduction in toughness and indentation measures in diabetic mice exhibiting 
increased AGEs levels9.
Regarding the bone macro- and microstructure, no consensus has been reached on the influence of T2DM 
on the trabecular bone architecture. Moreover, although most of the fractures in obesity induced-T2DM occur 
at sites that are rich in cortical bone10, the impact of T2DM on the cortical compartment is poorly understood. 
In both human and animal studies, cortical bone thickness has been reported to increase11,12, decrease13–15, or 
remain unchanged16–18. Also changes in intracortical porosity are highly controversial. For instance, Burghardt17 
and others14,19 reported increased cortical porosity in postmenopausal women with T2DM. However, another 
study indicated that cortical porosity is increased only in postmenopausal diabetics with a prior fragility fracture, 
and that diabetics without a prior fracture had similar cortical bone porosity as non-diabetic controls20. The 
cortical bone porosity, which includes the vascular canals and the osteocyte lacunar system, is an important con-
tributor of the skeletal health. On one hand, it is a determinant of bone strength and stiffness and might predict 
prevalent fractures independently of BMD21,22. On the other hand, the vascular supply to bone, in relation with 
the blood flow and nutrient supply, plays an important role in the maintenance and the healing of the tissue23. 
Therefore, given the incomplete understanding of the contributing factors to the poor skeletal health in T2DM, 
it is crucial to characterize the full 3D macro- and microstructure of the diabetic bone. As animal models are val-
uable tools for the investigation of diabetic complications, the present study aimed at exploring the influence of 
T2DM on the bone structural properties in the high fat diet (HFD) mouse model of obesity-driven T2DM. This 
well-described animal model closely parallels the common course of the human disease by firstly develop obesity 
so as to finally develop diabetes. 3D-investigation of the T2DM bone structural alterations was performed by 
using a desktop high resolution microfocus X-ray computed tomography (HR-microCT) approach. Not only this 
technique allows assessing the trabecular and cortical bone macrostructure, but it also provides quantification of 
the microstructure by isolating the vascular canal porosity independently from the lacunar porosity in the cortex 
at high resolution in a time and cost saving way.
Changes in the serum levels of bone turnover markers as well as detection of the cell death were also deter-
mined. Altogether, data gleaned from the present study provide a better characterization of the T2DM compro-
mised skeletal macro- and micro-architecture and, more specifically, highlight unrevealed T2DM-related changes 
in the cortical vascular porosity.
Results
Physiological parameters. As seen in Table 1, HFD mice had an obese phenotype evidenced by a 37.2% 
increased body weight compared to CTRL littermates (p < 0.001). HFD animals also showed significant fast-
ing hyperglycaemia (+ 89.7%, p < 0.001), along with a massive rise in HOMA-IR index (8.3-fold augmentation, 
p < 0.001) when compared to CTRL animals. The body weight in the CTRL group was significantly higher than 
that in the YNG group (p < 0.001). While the fasting blood glucose level was significantly lower (p = 0.041), the 
HOMA-IR was not statistically different (p = 0.058).
Bone macrostructure and bone remodelling. Trabecular macrostructure. Having checked the diabetic 
profile of the HDF animals, we then investigated the changes in trabecular architecture related to obesity-driven 
T2DM, and alternatively associated them with the ageing process (Fig. 1). Examination of the proximal tibia 
revealed that mice fed the HFD had significantly less (Fig. 1D) but thicker (Fig. 1B) trabeculae (− 56.2%; p < 0.001 
and + 33.0%; p < 0.001, respectively) compared to CTRL littermates although the spacing between the trabec-
ulae (Fig. 1C) had not changed significantly (p = 0.247). This resulted in an unchanged bone volume fraction 
(p = 0.165 – Fig. 1A). When compared to YNG mice, a lower trabecular BV/TV was evidenced in CTRL mice 
(9.28 ± 1.16% and 16.48 ± 1.96% for CTRL and YNG respectively, p = 0.007 – Fig. 1A) due to a significantly 
reduced trabecular thickness (p = 0.005 – Fig. 1B) and increased trabecular separation (p = 0.004 – Fig. 1C), but 
an unchanged trabeculae number (p = 0.059 – Fig. 1D). The decrease in trabecular thickness for the CTRL group 
when compared to HFD or to YNG mice is clearly illustrated on the thickness distribution plot (Fig. 1E) and on 
the color-coded 3D renderings of the thickness of the trabecular bone (Fig. 1F).
Cortical macrostructure. Regarding the cortical macrostructure (Fig. 2), both the 2 μ m and the 1 μ m voxel size 
scans showed that the Ct.Th was higher in HFD animals than in CTRL control animals (+ 21.1% for 2 μ m scans, 
p < 0.001 and + 20.0% for 1 μ m scans, p < 0.001 – Fig. 2A). In an obesity-driven T2DM-free environment, i.e. 
HFD CTRL YNG
Body weight (g) 42.80 ± 2.14*** 31.19 ± 1.39 22.74 ± 1.24***
Glycaemia (mg/dL) 307.50 ± 53.26*** 162.13 ± 24.35 197.71 ± 36.08*
HOMA-IR 42.75 ± 10.78*** 5.14 ± 2.97 9.61 ± 4.59
Table 1.  Body weight and metabolic parameters (mean ± SD) of HFD, CTRL and YNG animals. n = 7–8/
group.
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in normal ageing (CTRL group vs. YNG group), the Ct.Th decreased significantly by 13.6% for the 2 μ m scans 
(p = 0.012) and by 10.9% for the 1 μ m scans (p = 0.013). There was no significant difference between the 2 μ m and 
1 μ m voxel size results for the Ct.Th in the different groups, except for the CTRL group. In this group, the Ct.Th 
at 2 μ m voxel size was significantly underestimated (p = 0.031) by 0.9% when compared to 1 μ m voxel size scans. 
When the cortex outer diameter was concerned, both the 2 μ m and 1 μ m voxel size scans showed a significant 
increase for the HFD group compared to the CTRL littermates (10.5%, p = 0.001 and 10.4%, p = 0.001 respec-
tively – Fig. 2B), although there were significant differences (p < 0.001) between the 2 μ m and 1 μ m voxel size 
results for all the groups. The increase in the Ct.OD was not noticed in a normal ageing environment.
Figure 1. HR-microCT-based analysis of the (A) trabecular bone volume fraction, (B) trabecular thickness, (C) 
trabecular separation and (D) number of trabeculae for the HFD, CTRL and YNG groups. (E) The distribution 
plot of the trabecular thickness for the HFD, CTRL and YNG groups. (F) Typical color-coded 3D renderings of 
the trabecular architecture representing the thickness of the trabeculae. n = 7–8/group.
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The differences between the 2 μ m and 1 μ m voxel size scans are a result of the partial volume effect, which is 
smaller at higher resolution leading to a sharper bone surface (Fig. 2C–H). Although there were significant dif-
ferences between the 1 μ m and 2 μ m voxel size scans, the higher accuracy of the images did not reveal additional 
differences between the animal groups.
Bone resorption and bone formation. Given the macrostructural alterations, we next investigated the 
rate of bone turnover in our mice by measuring serum C-terminal telopeptide of type 1 collagen (CTX - Fig. 3A) 
and serum osteocalcin (OCN - Fig. 3B), biomarkers for bone resorption and formation respectively. When 
comparing YNG with CTRL animals, more bone resorption was noticed for the YNG group (29.7%, p < 0.001), 
but also more bone formation (131.0%, p < 0.001), hence indicating more bone remodelling (Fig. 3C; 78.0%, 
p < 0.001). The latter correlates well with the higher trabecular BV/TV (Pearson’s correlation coefficient = 0.94 – 
Fig. 1A). In HFD animals, there is less bone resorption (14.9%, p = 0.014), but also less bone formation (19.9%, 
p = 0.014) compared to the age-matched littermates. This might be linked with the increased trabecular thickness 
(Fig. 1B), and the decreased trabecular number (Fig. 1D) for the HDF group. They have only slightly less bone 
remodelling compared to the CTRL group (5.8%, p = 0.63 – Fig. 3C), which again correlates well with the trabec-
ular BV/TV being not significantly different for both groups (Fig. 1A).
Bone vascularity. Microstructural characterization. When evaluating the vascular canal system in the cor-
tex at 2 μ m voxel size (Fig. 4), there was no significant difference in the average vascular canal porosity (p = 0.225 
– Fig. 4A) neither in the vascular canal diameter (p = 0.535 – Fig. 4B) in HFD animals compared to the CTRL 
group, despite a significant lower vascular canal density (− 55.0% decrease in HFD animals, p = 0.034 – Fig. 4C). 
In normal ageing, only the density of the vascular canals was found significantly increased in CTRL animals 
(p = 0.021 – Fig. 4C).
Figure 2. HR-microCT-based analysis of the (A) cortex thickness and (B) cortex outer diameter. Statistical 
comparison has been made between the different animal groups (HFD and YNG versus CTRL), indicated with 
an asterisk for both scanning resolutions, and between the 2 μ m and 1 μ m voxel size scans per animal group, 
indicated with an §. The percentage under the bar graph per animal group represents the relative difference 
between the 2 μ m and 1 μ m voxel size scans. Typical cross-sectional HR-microCT images of the cortex of a (C,F) 
HFD, (D,G) CTRL and (E,H) YNG animal scanned at (C–E) 2 μ m voxel size and (F–H) 1 μ m voxel size. Red 
arrows indicate vascular canals, black arrows indicate osteocyte lacunae that can be segmented and quantified 
and blue arrows indicate osteocyte lacunae that cannot be segmented from the cortical bone. Scale bars = 200 μ m, 
n = 7–8/group.
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In contrast, the datasets acquired at 1 μ m voxel size revealed a significant drop (− 32.7%; p = 0.019) in vascular 
canal porosity in HFD mice when compared to CTRL controls. The HFD group also exhibited a lower vascular 
canal density (61.2% lower than CTRL group, p = 0.002), whereas the diameter of the canals remained unchanged 
(p = 0.572). Vascular canal parameters in CTRL animals were not significantly different from those in the YNG 
group, suggesting that the compromised vascular cortical porosity in HFD mice was likely to result from the 
obesity-driven T2DM environment rather than from ageing. Histological examination of H&E stained sections 
corroborated HR-microCT data (Fig. 5).
Paired t-tests highlighted the important effect of the spatial image resolution on the quantification of the 
vascular porosity. The largest influence was seen for the vascular canal density. When compared to the 1 μ m 
voxel size scans, the vascular canal density at 2 μ m voxel size was underestimated by 95.9% for the HFD group 
(p = 0.005), by 127.4% for the CTRL group (p = 0.004) and by 344.9% (p = 0.001) for the YNG group. Inspections 
of the datasets revealed that the 2 μ m voxel size images (Fig. 4D–F) produced a less continuous delineation of 
the vascular canals (Fig. 4J–L – white arrows) than the 1 μ m voxel size images (Fig. 4G–I) and lacked the thinner 
canals (Fig. 4J–L – yellow arrows). Vascular canals also appeared thinner at 2 μ m voxel size than at 1 μ m voxel size, 
resulting in a reduction by 11.8%, 10.1% and 16.2% in HDF (p = 0.104), CTRL (p = 0.001) and YNG (p = 0.33) 
animals respectively in the vascular canal diameter. Consequently, the cortical vascular porosity at 2 μ m voxel 
size was largely underestimated in the three groups (− 18.3% for HFD, p = 0.352, − 36.9% for CTRL, p = 0.001 
and − 21.5% for YNG, p = 0.033) when compared to the 1 μ m voxel size.
Bone osteocyte lacunar system. Microstructural analysis. Analysis of the lacunar system at 1 μ m voxel 
size using a despeckling volume of 280 μ m3, including the lacunar porosity (Fig. 6A), density (Fig. 6B) and diam-
eter (Fig. 6C), did not reveal significant differences neither in the obesity-driven T2DM environment (HFD vs. 
CTRL animals) nor in normal ageing (CTRL vs. YNG animals). This was also confirmed in the 3D renderings 
of the images (Fig. 6D–F). A decreasing trend in lacunar porosity and density could however be noticed due to 
ageing, and also when comparing the HFD group with the CTRL controls. Additionally, although not statistically 
significant, the lacunar diameter was on average lower for the CTRL group compared to both the YNG and the 
HFD group.
Viability of the osteocytes - TUNEL staining. Following the characterization of the osteocyte lacunar system, 
we then investigated the integrity of the cells within the lacunae by assessing osteocyte viability. Prevalence of 
apoptotic TUNEL positive osteocytes within the cortex is shown on Fig. 7C–E. Quantitative analysis of these 
images indicated a significantly lower percentage of TUNEL-positive osteocytes for the YNG group compared 
to the CTRL group (9.26 ± 5.29% and 33.22 ± 11.64% respectively; p = 0.031 – Fig. 7A), while no significant 
differences were found between the CTRL and the HFD group (25.97 ± 17.87%, p = 0.59). When combining the 
percentage of TUNEL-negative osteocytes with the HR-microCT-based lacunar density (Fig. 7B), a significant 
difference appeared when comparing the CTRL with the YNG group (12285.41 ± 4806.74 osteocytes/mm3 and 
18990.67 ± 4888.98 osteocytes/mm3 respectively, p = 0.031). CTRL and HFD animals (12227.53 ± 4916.64 oste-
ocytes/mm3) showed to have a similar density of TUNEL-negative osteocytes (p = 0.99).
Discussion
T2DM is a complex and multifactorial disease largely resulting from a Western style diet and an excessive weight. 
T2DM does not spare the skeletal system and is associated with bone fragility and poor bone healing24,25. We 
hypothesized that a contributing factor to these impairments would be the alteration in vasculature and architec-
ture of the bone. Therefore, we assessed the macro- and microstructure of T2DM bone in the HFD–fed C57BL/6J 
mouse model in a detailed and 3D manner using HR-microCT, and substantiated these results using histomor-
phometry and immunoassays.
Our findings revealed T2DM related changes in the structural pattern of the trabecular and the cortical com-
partments. The use of a group of young animals allowed us to assess the mere age-induced effects on bone homeo-
stasis in the current experiments. Indeed, in comparison with YNG animals, CTRL mice displayed an osteopenic 
trabecular bone phenotype characterized by a decreased trabecular bone volume fraction and thickness and an 
increased separation, along with a decreased bone resorption and formation (as indicated by the CTX and OCN 
expression). This trabecular bone loss bears a remarkable resemblance to age-related changes in humans26. HFD 
Figure 3. Elisa-based measurements of the (A) CTX and (B) OCN expression in murine blood serum, and (C) 
the ration of (B) over (A). n = 6–8/group.
www.nature.com/scientificreports/
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Figure 4. HR-microCT-based analysis of the (A) cortex vascular porosity, (B) vascular canal diameter and (C) 
vascular canal density for the HFD, CTRL and YNG groups. Statistical comparison has been made between the 
different animal groups (HFD and YNG versus CTRL, indicated with an asterisk) for both scanning resolutions, 
and between the 2 μ m and 1 μ m voxel size scans (indicated with an §) per animal group. The percentage under 
the bar graph per animal group represents the relative difference between the 2 μ m and 1 μ m voxel size scans. 
Representative 3D renderings of the vascular canals of a (D,G) HFD, (E,H) CTRL and (F,I) YNG animal scanned 
at (D–F) 2 μ m voxel size and (G–I) 1 μ m voxel size. As indicated, distance between the marks on the bounding box 
is 100 μ m. Zoom of the dotted area in the 2 μ m and 1 μ m voxel size images of a (J) HFD, (K) CTRL and (L) YNG 
animal, where the red canals represent the 2 μ m voxel size scan and the blue canals the 1 μ m voxel size scan. Missing 
connections in the 2 μ m voxel size scans are indicated with white arrows and canals only present in the 1 μ m voxel 
size scans are indicated with yellow arrows. n = 7–8/group.
www.nature.com/scientificreports/
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mice had a similar trabecular bone mass to that of the CTRL animals, which is in contrast to several earlier stud-
ies13,15,27, but supports the recent works from Doucette et al. and Lecka Czernik et al.18,28. Although HFD animals 
showed a similar ratio of OCN/CTX, they did have a significantly decreased bone resorption and formation com-
pared to the CTRL controls, as also has been indicated by Starup-Linde et al. 29 The decreased Tb.N in the HFD 
mice confirms all the previous studies in the field regardless the duration of the HFD or the bone piece15,16,18,30. 
Changes in trabecular thickness in response to the HFD in mouse tibia are conflicting in the literature16,28,30.
Because changes in cortical porosity were found to be “ageing-independent” in our study, we can assume that 
the decrease in vascular porosity was related to the HFD phenotype of obesity-driven T2DM. More research 
needs to be done to investigate whether the impaired vascular porosity, which may contribute to the poor bone 
healing in the T2DM environment31, is driven by the direct action of HFD on angiogenesis, resulting in an alter-
ation of the bone architecture, or whether HFD primarily affects bone cells, subsequently leading to defective 
vasculature.
In contrast to our work, HR-pQCT-based studies in human suggested that T2DM in postmenopausal women 
is associated with abnormal high cortical porosity14,17,19. Interestingly however, although cortical porosity is asso-
ciated with increased bone turnover32,33, a number of studies paradoxically showed reduced bone turnover in 
patients with T2DM34,35, similar to our own findings (i.e. CTX and OCN measurements). In 2013, new elements 
were provided by Patsch et al. by reporting that changes in porosity are dependent of the history of fractures20. 
They found evidence that cortical porosity was only strongly related to a prior history of fracture in those with 
diabetes and was not a characteristic of diabetes in general. Indeed, cortical porosity tented to be lower although 
not statistically different in diabetics without fragility fractures than healthy controls. In light of these observa-
tions, our results, that seemed inconsistent with literature at first, provided new insight into the assessment of the 
human diabetic bone.
A limitation of the present study is the HFD model itself, which does not allow separating the effects of hyper-
glycaemia per se, insulin resistance, excess body weight and ageing on the skeletal response. Mechanical test-
ing has indicated a significant decrease in the bending stiffness of HFD bones compared to the CTRL group 
(Supplementary data – Supplementary Figure S1). However, in order to determine what the mechanisms are 
behind the decreased mechanical properties, and whether this decrease is the result of the altered macro- and 
micro-architecture, or a change in the bone composition due to the decreased cortical vascularization, and hence 
lower nutrient supply, or a combination of both, additional experiments need to be performed. The use of com-
putational modelling, additional mechanical testing including micro- or nano-indentation, bone compositional 
analysis or the study of a non-transgenic mouse model, obese but free of metabolic disorder, would be helpful in 
dissecting the underlying mechanisms of the T2DM bone mechanical alterations.
Our study also showed the important influence of the spatial image resolution on the quantification of the 
vascular system in the cortex. Although scanning at a 2 μ m voxel size has been suggested to be appropriate for 
measuring the vascular porosity36, we have shown that this resolution was not sufficient to pick up the smaller 
vascular canals and resulted in a significant underestimation of the vascular canal density and porosity of the cor-
tex. As a consequence, the difference in the vascular porosity between the HFD group and the CTRL controls was 
only picked up at 1 μ m voxel size. This resolution has indeed been shown to be relevant when assessing vascular 
and lacunar porosities in rats36 and in mice37. Compared to these studies, however, where the scanning times went 
up to about 5 hours per sample, in our study the scanning time was only 20 minutes per sample, making routine 
analysis possible in a time and cost saving way38. The short scanning time in our study also prevented drying of 
the sample during scanning, which not only could have an influence on the image quality (i.e. movement arte-
facts), but also could affect subsequent immunohistological analysis of the samples, adding to the potential value 
Figure 5. Representative H&E-stained histological sections of the cortex (longitudinal sections) of a (A) HFD, 
(B) CTRL and (C) YNG mouse. ‘BV’ indicates blood vessels where the erythrocytes are clearly visible, while the 
black arrows point out osteocyte lacunae. Scale bar = 100 μ m.
www.nature.com/scientificreports/
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of the use of HR-microCT. It is important to highlight that the HR-microCT measurements, without the use of 
a contrast agent, only allow visualizing and quantifying the vascular cortical porosity and not the blood vessels 
as such. As a consequence, it is not possible to discern permanent blood vessels from remodelling units, or to 
exclude that in some canals no blood vessels are present.
One of the major concerns in the study of the T2DM-related complications is the relevance of the model 
in regards to the human condition. Since obesity is the major environmental factor predisposing to T2DM, we 
selected a rodent model recognized to closely parallel the common course of the human disease by firstly develop 
obesity so as to finally develop diabetes39. However, the development of overt diabetes is controversial in this 
Figure 6. HR-microCT-based analysis of the (A) cortex lacunar porosity, (B) lacunar diameter and (C) lacunar 
density for the HFD, CTRL and YNG groups. Typical 3D renderings of the lacunar system of a (D) HFD, (E) 
CTRL and (F) YNG. As indicated, distance between the marks on the bounding box is 100 μ m. n = 7–8/group.
Figure 7. TUNEL-based measurements of the (A) percentage of TUNEL+ osteocytes and (B) the lacunar 
density of TUNEL− osteocytes (using HR-microCT data) for HFD, CTRL and YNG animals. n = 3–4/group. 
Typical TUNEL-stained cross-sections of the cortex of a (C) HFD, (D) CTRL and (E) YNG mouse. Brown 
osteocytes are TUNEL+ and are apoptotic. Blue osteocytes are TUNEL−. Scale bars = 50 μ m.
www.nature.com/scientificreports/
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animal model and the vulnerability of C57BL/6J individuals to the HFD is variable40,41. Therefore, we controlled 
the main manifested pictures of T2DM in our animals by showing a rise in fasting glucose level, insulin resistance 
and body weight in mice fed the HFD. Given the mechanosensory role of osteocytes and their newly recognized 
endocrine function42, we further explored the osteocyte and its lacunar system, expecting to see changes in the 
HFD animals. Despite a lack of statistical evidence, our results regarding the lacunar density, scanned at 1 μ m 
voxel size, followed a slight downward trend but similar to that seen in the work of Lai and co-workers in a spon-
taneous type 1 diabetic (T1DM) mouse model43. The authors suggested that the decrease is possibly due to the 
impaired osteoblast differentiation commonly associated with diabetes. However, apart from the considerable 
standard deviation on the results due to differences between animals within one group, it is possible that the spa-
tial resolution (1 μ m voxel size) used in this study for the quantitative assessment of the osteocyte lacunar porosity 
was not sensitive enough to pinpoint differences among the experimental groups. The use of synchrotron X-ray 
computed tomography38, allowing also an increased contrast resolution, could be a solution to validate the results 
from this study and to determine whether the osteocyte lacunar porosity is modified due to T2DM or not.
As expected, apoptotic osteocytes were found higher in the cortical bone of the CTRL group compared to 
the YNG group. Recently, it has been shown that treatment of osteocyte like MLO-Y4 cells with high glucose 
concentrations and AGEs induces their apoptosis44. Besides, previous in vivo studies indicated that excessive 
loading increases the prevalence of osteocyte apoptosis45,46. Hence, our TUNEL assay showing a high rate of dead 
osteocytes in the HFD animals was not surprising, albeit we would have expected a higher prevalence of apop-
totic osteocytes in HFD than CTRL animals. Osteocyte apoptosis controls the activation of the intracortical bone 
remodelling by triggering osteoclast-mediated bone resorption47. It would be interesting to test whether or not a 
longer high fat diet challenge would be associated with a higher prevalence of TUNEL+ osteocytes and related 
bone resorption.
In conclusion, our HR-microCT analysis indicates that obesity-driven T2DM induced by a 14 week-HFD 
affects both macro- and microstructure of bone in C57BL/6J mice, and this is corroborated by histomorpho-
metry and immunoassays. Specifically, it is associated with a thickening and widening of the cortical bone and 
thickening of the trabeculae along with a decrease in their number, and a reduced bone resorption and formation. 
Moreover, we show that obesity-driven T2DM compromises the intracortical vascular porosity. This unprece-
dented ultra-characterization can provide novel insight into the T2DM-related compromised skeletal macro- and 
micro-architecture, and illustrates in addition the potential added value of HR-microCT imaging when assessing 
the macro- and microstructure of the rodent bone.
Materials and Methods
Animal care and diets. All animal procedures were performed with approval of the Medical and Animal 
Ethics Committee of the KU Leuven, in accordance with the ARRIVE guidelines and the ILAR Guide to the Care 
and Use of Experimental Animals. Inbred male C57BL/6 mice were housed with free access to water in a temper-
ature- and light-controlled vivarium housing room on a 12-hour light/dark cycle. Three groups were assessed in 
this study. At 8 weeks of age, mice were randomly assigned to the high fat diet group (HFD group, n = 7) or the 
age-matched control group (CTRL group, n = 8) and were fed either a high fat diet (60% energy as fat, Ref No 
D12492, Open Source Diets, Research Diets Inc., New Brunswick, NJ, USA) or normal chow (11% energy as fat, 
Ref No S8189-S085, Ssniif, Germany) respectively. Mice were fed ad libitum for a period of 14 weeks, at which 
time point they were sacrificed. To evaluate the effect of ageing, a third group of lean young mice fed normal chow 
was sacrificed at 8 weeks of age (YNG group, n = 8). All animals were euthanized through intracardiac puncture 
under isoflurane anaesthesia and tissues were collected for analysis.
Physiological assessment of T2DM. Obesity-driven T2DM was assessed at the time of sacrifice by meas-
uring the body weight, the fasting glycaemia and the fasting insulin level. Mice were fasted for 6 hours prior to 
euthanasia. Fasting blood glucose levels were determined from tail vein blood samples using an Accu-Chek Aviva 
glucose meter (Roche Diagnostics, Vilvoorde, Belgium). Quantitative determination of fasting plasma insulin 
was performed by immunoassay (Mercodia Mouse Insulin Elisa, Uppsala, Sweden). Insulin resistance is defined 
as a state in which a normal or elevated insulin level produces an inadequate biological response. As a hallmark 
of T2DM, insulin resistance was assessed in our animals using the homeostasis model assessment (HOMA-IR) 
originally described by Hunter et al.48. HOMA-IR index scores were calculated as HOMA-IR = (FBG x FPI)/405, 
where FBG denotes fasting blood glucose (mg/dL) and FPI is fasting plasma insulin (mU/mL). The factor 405 
accounts for the measurement unit.
High resolution microfocus X-ray computed tomography (HR-microCT) – acquisition. After 
harvesting, the tibias were fixed in a freshly prepared 4% paraformaldehyde solution for 1 day and transferred to 
phosphate-buffered saline (PBS) for storage. Then, they were scanned at two different spatial resolutions (Fig. 8) 
using HR-microCT (Phoenix NanoTom S, GE Measurement and Control Solutions).
First, the proximal tibiae were examined at 2 μ m isotropic voxel size to assess the trabecular and cortical mac-
rostructure. The source, equipped with a tungsten target, was operated at 70 kV and 120 μ A. An aluminium filter 
of 0.3 mm was applied to reduce beam hardening. Because the ‘fast mode’ settings (i.e. exposure time 500 ms, 
frame averaging 1 and skip 0) were used, the scanning time was only 20 minutes per sample.
In order to be able to separate the intracortical lacunar-canalicular porosity surrounding osteocytes 
from the vascular porosity, the tibiae were then scanned at 1 μ m voxel size (Fig. 8). The limited field of view 
(2.3 mm × 2.3 mm) at 1 μ m isotropic voxel size did not allow scanning the entire tibia because of its curvature. 
Thus, tibias were cross-sectioned at mid-diaphysis. The source was set at 70 kV and 60 μ A, and an aluminium filter 
of 0.3 mm was used to reduce beam hardening. Application of the ‘fast mode’ settings resulted again in a scanning 
time of 20 minutes per sample.
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High resolution microfocus X-ray computed tomography (HR-microCT) – image analysis. 
Images were analysed using CTAn (Bruker MicroCT, Kontich, Belgium). For the assessment of the trabecular 
architecture, we selected 600 images (1.2 mm height) starting at 800 μ m below the growth plate level. On this 
dataset, a region of interest (ROI) was drawn manually incorporating the trabecular structure, but not including 
the cortical bone. Using automatic Otsu segmentation, the images were binarised, and noise was removed by a 
closing operation (round kernel, radius 1, 3D space) and a double despeckling step (removal of black and white 
speckles respectively, 3D space, less than 200 voxels). Using 3D analysis, the trabecular volume in the total ROI 
volume (BV/TV), trabecular number (Tb.N), thickness (Tb.Th) and separation (Tb.Sp.) were calculated. The 
trabecular thickness distribution was visualized in 3D using CTVox (Bruker MicroCT, Kontich, Belgium).
Analysis of the cortical macrostructure and porosity at mid-shaft tibia (vascular porosity in the 2 μ m voxel 
size scans, and vascular and osteocyte lacunar porosity in the 1 μ m voxel size scans) was performed on 1.2 mm 
high datasets (600 images for the 2 μ m voxel size scans, and 1200 images for the 1 μ m voxel size scans). First, both 
2 μ m and 1 μ m scans were oriented in the same plane, using DataViewer (Bruker MicroCT, Kontich, Belgium). 
Then, we selected the same cortical midshaft region in order to be able to compare the 2 μ m voxel size scans with 
the 1 μ m voxel size scans. The ROI fitting the cortical bone was drawn automatically using an in-house developed 
protocol. Using manual global segmentation, the images were binarised for the pores, and noise was removed 
by a despeckling step, i.e. removal of white speckles in 3D space less than 280 μ m3 (35 voxels for the 2 μ m voxel 
size scans and 280 voxels for the 1 μ m voxel size scans). To evaluate the sensitivity of the despeckling step on the 
cortical lacunar porosity, lacunar diameter and number of lacunae, and to determine the most optimal despeck-
ling value for our study, we ranged the white speckle volume from 220 μ m3 up to 340 μ m3 (based on literature) in 
steps of 30 μ m3, and also included more extreme values (150 μ m3, 450 μ m3 and 550 μ m3). Based on these results, 
we selected a threshold of 280 μ m3 as lower limit despeckling volume (Supplementary data - Supplementary 
Figure S2). All the remaining pores were assigned as vascular plus lacunar pores, and the cortical porosity was 
determined. After a following despeckling step to remove white speckles smaller than 4000 μ m3, only the vascular 
pores remained, and the vascular canal density (number per mm3- N.Ca/Ct.TV, #/mm3), diameter (Ca.D, μ m) 
and porosity (Ca.V/Ct.TV, %) were calculated. Finally, the dataset was reloaded, white speckles smaller than 
280 μ m3 and larger than 4000 μ m3 were removed by despeckling, and the lacunar density (N.Lc/Ct.TV, #/mm3), 
diameter (Lc.D, μ m) and porosity (Lc.V/Ct.TV, %) was determined. For the different steps, the binarised images 
Figure 8. Schematic representation of the HR-microCT acquisition strategy: 2 μm voxel size scan versus 
1 μm voxel size scan. 
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of the pores were saved, and the vascular and lacunar (only for the 1 μ m voxel size scans) porosity was visualized 
in 3D using CTVox. To determine the cortical thickness (Ct.Th, μ m), the thickness of the ROI was calculated both 
for the 2 μ m and 1 μ m voxel size scans, as this fits perfectly around the cortex and does not include the cortical 
porosity. When then filling up the marrow cavity, the cortical outer diameter (Ct.OD, μ m) was determined on the 
2D sections based on the plate model where Ct.OD = 2/(surface/volume).
Histology and histomorphometry. After HR-microCT imaging, decalcified samples were embedded in 
paraffin and sectioned (5 μ m thick). Standard Haematoxylin and Eosin (H&E) staining was used for the visual 
inspection of the cortical vascular and lacunar porosity. Terminal deoxynucleotidyl transferase dUTP nick end 
labeling (TUNEL) staining was performed using the ApopTag® peroxidise In Situ Apoptosis Detection Kit S7100 
(Millipore, Guyancourt, France). In the counting of the TUNEL-positive and negative osteocytes, only osteocytes 
in the mid-diaphysis of tibias which were recognized based on their morphology were counted.
Immunoassays. CTX and OCN ELISA. Serum from 6 animals per group was collected after the blood was 
allowed to clot for 2 h at room temperature. Serum C-terminal telopeptide of type 1 collagen (CTX) and serum 
osteocalcin (OCN) were measured using ELISA kits (i.e. RatLapsTM (CTX-I) EIA from Immunodiagnosticsystem 
and mouse Osteocalcin ELISA kit from Immunotopics, Inc. respectively).
Statistical analysis. Data for all parameters are expressed as group means ± standard deviation (SD). 
Sample size calculation (n = 7–8 animals/group) was carried out using the resource equation method49. Analysis 
of normality of the data was performed using the Shapiro-Wilk test and the presence of outliers was tested using 
the Dixon test. Equality of variances was assumed when the F-test (normally distributed) or Levene’s test (not 
normally distributed) revealed values of p > 0.05. HFD group and YNG group were both independently com-
pared to CTRL animals using a two-tailed unpaired t-test (normally distributed) or a Kruskal-Wallis test (not 
normally distributed) with equal or unequal variance depending on the F-test or Levene’s test respectively. Since 
the HFD model needs a combination of time (ageing) and diet to generate T2DM, we cannot assume that these 
factors are truly independent. For this reason, we could not perform a one-way ANOVA and could not compare 
the HFD with the YNG group. To compare the 2 μ m voxel size scans with the 1 μ m voxel size scans, a paired t-test 
was used. All statistical analysis was performed using Sigma Plot (Systat Software, Inc., San Jose, CA, USA). 
Significance is indicated as follows: *p < 0.05, **p < 0.01, and ***p < 0.001 when compared to the CTRL group; 
§p < 0.05, §§p < 0.01, and §§§p < 0.001 when comparing the 2 μ m voxel size scans with the 1 μ m voxel size scans.
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